 Exclusive licensing and distribution agreement signed with Salus Pharmaceuticals in Lithuania, Estonia, Latvia, Croatia, Slovenia, Serbia, North Macedonia, Montenegro and Bosnia First commercial launches planned later this year Liège, Belgium 24 January 2023 7AM CET Hyloris Pharmaceuticals SA Euronext Brussels: HYL, a specialty biopharma company committed to addressing unmet medical needs through reinventing... The post Hyloris Announces Commercial Partnership for Maxigesic IV in 9 Europe... 